Skip to main content
Premium Trial:

Request an Annual Quote

David Reiter, Kevin Ryan, John Rakitan, Gary Wolfe, Guy della Cioppa, Ronal Artale, John Chute, Michael Johnson, Richard Morimoto, Andrew Mesecar, Bernard Santarsiero, Richard van Breemen, Steven Schiltz, Cheryl Janson

Premium

David Reiter has become vice president, general counsel, and corporate secretary of Luminex. Reiter was previously general counsel for 724 Solutions and senior counsel for Compaq Computer.


Eclipse Diagnostics, Large Scale Biology’s new diagnostics subsidiary that plans to market mass spec-based pattern recognition technology, announced its management team. Kevin Ryan, president and CEO of LSBC, will also serve as Eclipse’s president. He holds a bachelor’s degree in business and marketing from the University of Notre Dame. John Rakitan will be the company’s senior vice president and general manager, in addition to being senior vice president, general counsel, and secretary at LSBC. Rakitan holds a JD from the University of Notre Dame and a BS in biology from Northern Illinois University. Gary Wolfe will serve as Eclipse’s senior vice president and CSO. Wolfe received a BS in chemistry from the University of California, Los Angeles, and a PhD in physical chemistry from the University of Washington. Guy della Cioppa will be the company’s senior vice president for business development. He joins Eclipse from NanoInk, where he was executive vice president of business development. He holds a PhD in biology from the University of California, Los Angeles. Ronal Artale will serve as the company’s senior vice president and CFO. He is also senior vice president, COO, and CFO at LSBC. Artale holds an MBA in finance from St. John’s University. Additionally, John Chute has been appointed to Eclipse’s scientific advisory board. He is a hematologist-oncologist and an associate professor at the Duke University Medical Center. Prior to that, he was vice president for medical affairs at LSBC. Chute holds an undergraduate degree from the University of Notre Dame and a medical degree from Georgetown University School of Medicine.


Shamrock Structures of Woodrige, Ill., has appointed the following scientific advisory board: Michael Johnson, a professor of medicinal chemistry and pharmacognosy at the University of Illinois at Chicago (UIC); Richard Morimoto, a professor of biology at Northwestern University; Andrew Mesecar, an assistant professor of medicinal chemistry and pharmacognosy at UIC; Bernard Santarsiero, a research professor at UIC and a co-founder of Syrrx; and Richard van Breemen, a professor of medicinal chemistry and pharmacognosy at UIC. In addition, Steven Schiltz has become CEO and Cheryl Janson has been named director of protein crystallization of the company.

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.